{"issuance_frequency":"","notes_translated":{"fr":"Cette ligne directrice s'applique aux promoteurs qui comptent apporter des changements à des drogues nouvelles pour lesquelles un AC a été délivré aux termes de l'article C.08.004 du Règlement sur les aliments et drogues. Il peut s'agir de produits pharmaceutiques, de produits biologiques et de produits radiopharmaceutiques pour usage humain, ainsi que de produits pharmaceutiques, de produits radiopharmaceutiques et de certains produits biotechnologiques pour usage vétérinaire.","en":"This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. This may include pharmaceuticals, biologics and radiopharmaceuticals for human use and pharmaceutical, radiopharmaceutical and certain biotechnological products for veterinary use."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"f5e9bc41-83a9-44b2-9bcc-4be7e12d61f4","metadata_created":"2021-07-07T19:51:32.384708","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-07T19:51:32.384715","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Post-avis de conformité","changements d'AC","directives de qualité","changements aux nouveaux médicaments","article C.08.004 du Règlement sur les aliments et drogues","produits pharmaceutiques","produits biologiques","radiopharmaceutiques","médicaments à usage humain","médicaments biotechnologiques à usage vétérinaire"],"en":["Post-Notice of Compliance","NOC Changes","quality guidance","changes to new drugs","section C.08.004 of the Food and Drug Regulations","pharmaceuticals","biologics","radiopharmaceuticals","drugs for human use","biotechnological drugs for veterinary use"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice : Changements survenus après l’avis de conformité (AC) : Document sur la qualité","en":"Post-Notice of Compliance (NOC) Changes – Quality Guidance "},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"f5e9bc41-83a9-44b2-9bcc-4be7e12d61f4","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1b4ceb68-e399-4f89-8956-a98a8bb97071","related_relationship":"","name_translated":{"fr":"Ligne directrice : Changements survenus après l’avis de conformité (AC) : Document sur la qualité","en":"Post-Notice of Compliance (NOC) Changes – Quality Guidance "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Post-Notice of Compliance (NOC) Changes – Quality Guidance ","language":["en"],"created":"2021-07-07T19:51:32.514131","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/quality-document/guidance.html#t1","last_modified":null,"position":0,"revision_id":"74bf5243-6441-4e20-9367-0a0bc8871eef","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"f5e9bc41-83a9-44b2-9bcc-4be7e12d61f4","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e550ac3a-61a0-437d-b02a-d3a9073e3a55","related_relationship":"","name_translated":{"fr":"Ligne directrice : Changements survenus après l’avis de conformité (AC) : Document sur la qualité","en":"Post-Notice of Compliance (NOC) Changes – Quality Guidance "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Post-Notice of Compliance (NOC) Changes – Quality Guidance ","language":["fr"],"created":"2021-07-07T19:51:32.514137","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/changements-survenus-apres-avis-conformite/document-qualite/lignes-directrices.html#t1","last_modified":null,"position":1,"revision_id":"74bf5243-6441-4e20-9367-0a0bc8871eef","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-08-26 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"f5e9bc41-83a9-44b2-9bcc-4be7e12d61f4","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. This may include pharmaceuticals, biologics and radiopharmaceuticals for human use and pharmaceutical, radiopharmaceutical and certain biotechnological products for veterinary use.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Post-Notice of Compliance (NOC) Changes – Quality Guidance ","revision_id":"74bf5243-6441-4e20-9367-0a0bc8871eef"}